default image

Urologie

Information and services of the department

  • Number of inpatient cases: 170

Zusätzlich wurden 22 Hybrid-DRG-Fälle erbracht: L17N 6 L20M 7 L20N 9

Services search (in the department)


Illness Number of cases
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral calculi - Hydronephrosis in obstruction by ureteral calculi (N13.21) 26
Malignant neoplasm of bladder - Malignant neoplasm of overlapping sites of bladder (C67.8) 25
Hyperplasia of prostate (N40) 21
Malignant neoplasm of bladder - Malignant neoplasm of lateral wall of bladder (C67.2) 12
Malignant neoplasm of bladder - Malignant neoplasm of posterior wall of bladder (C67.4) 10
Obstructive and reflux uropathy - Obstructive and reflux uropathy unspecified (N13.9) 7
Unspecified haematuria (R31) 6
Malignant neoplasm of prostate (C61) 4
Obstructive uropathy and refluxuropathy - Hydronephrosis in obstruction by renal and ureteral stone - Hydronephrosis in obstruction by renal and ureteral stone stone location unspecified (N13.29) 4
Calculus of kidney and ureter - Calculus of kidney (N20.0) 4
Treatment Number
(5-98k.0) 72
Surgical incision, removal or destruction of diseased tissue in the urinary bladder, with access through the urethra (5-573.40) 56
Insertion, exchange or removal of a ureteral stent (8-137.00) 39
X-rays of the kidney and urinary tract with contrast medium (3-13d.5) 36
Insertion, exchange or removal of a ureteral stent (8-137.10) 32
Computed tomography (CT) of the abdomen without contrast medium (3-207) 24
Injection or administration of medicines into the urinary bladder (8-132.3) 15
Dilatation of the ureters during an operation or endoscopy (5-560.2) 14
Surgical removal or destruction of prostatic tissue through the urethra (5-601.0) 12
Surgical removal or destruction of prostatic tissue through the urethra (5-601.1) 12

Hospital information and services for all specialist departments

External comparative quality assurance
Further information
Bezeichnung
Teilnahme externe Qualitätssicherung 0
Bezeichnung
Teilnahme externe Qualitätssicherung 0
Bezeichnung
Teilnahme externe Qualitätssicherung 0
  • Quality of participation in the Disease Management Programme (DMP)
    No participation
Number Group
33 Medical specialists (m/f) , psychological psychotherapists (m/f) and child and adolescent psychotherapists (m/f) who are subject to the obligation to undergo further training*
28 Number of medical specialists (m/f) from no. 1 who have completed a five-year period of further training and are therefore subject to the obligation to provide evidence
28 Number of those persons from no. 2 who have provided proof of further training according to Article 3 of the G-BA regulations
* according to the “Provisions of the Joint Federal Committee for the Further Training of Medical Specialists (m/f), Psychological Psychotherapists (m/f) and Child and Adolescent Psychotherapists (m/f) in Hospitals”
Job Explanation
Lectureships / teaching posts at colleges and universities
Student training (clinical traineeship / internship year)
No. Training in other healing professions Comment
HB19 Nursing professionals
HB17 Auxiliary nurse (m/f)
HB15 Anaesthesia technical assistant (m/f)
HB07 Surgical technical assistant (m/f)

Thorsten Sleifir

Klinikgeschäftsführer

Phone: 07631 -88-4006
Mail: ed.tiehdnuseg-soileh@rifiels.netsroht

Dr. med. Sascha Al Agha

Ärztlicher Direktor

Phone: 07631 -88-1122
Mail: ed.tiehdnuseg-soileh@ahgAlA.ahcsaS

Dr. med. Sascha Al Agha

Vorsitzender der Hygienekommission, Ärztlicher Direktor

Phone: 07631 -88-1122
Mail: ed.tiehdnuseg-soileh@ahgAlA.ahcsaS